Senators did not approve the 9-nominee commission to reshape the Veteran Affairs health care system; US population is getting older and more diverse; HHS issued guidance to protect patient privacy related to sexual and reproductive care.
A bipartisan group of 12 senators decided not to approve the 9 nominees for a Veteran Affairs (VA) commission that would reshape the VA health care system, The Washington Post reported. As part of this reshaping, the commission would be tasked with weighing recommendations from 1200 VA hospitals and clinics, hold hearings in affected areas, and modernize outdated hospitals. According to the 12 senators, major reasons for this decision were high costs, short time frame, and past recommendations that the senators deemed not reflective of a common final goal.
According to updated Census Bureau data, the US population is continuing a trend seen over the last 2 decades where it is getting older and more diverse. The Washington Post reported that, since 2000, the median age increased by 3.4 years to 38.8, with 47 states seeing an increase median age between 2020 and 2021. The Census data also showed an increase in all non-White race and ethnicity groups between 2020 and 2021, while the White population declined by .03%. In the same period, the Native Hawaiian and other Pacific Islander population grew the fastest, increasing by 1.54%, while the Hispanic population grew the most numerically by 767,907 people.
HHS issued guidance Wednesday that health care providers are not required to disclose individuals’ private health information relating to sexual and reproductive care, and are often legally prohibited from doing so. As reported by Bloomberg, this guidance was announced as an effort by the Biden administration to assure that sensitive information related to reproductive health, including abortions, can be protected from law enforcement following the overturning of Roe v Wade. Separate from the guidance, the Biden administration is preparing a letter to be sent as soon as this week requesting that the Federal Trade Commission protects women’s privacy when seeking care or disclosing personal information regarding reproductive health care, including preventing companies from collecting and selling certain data on apps.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More